As Figure 1A illustrates, the GBM patients exhibited a significantly (p < 0.0001) higher mean SCF plasma level (2.80 ± 1.52 ng/ml) than the healthy controls (0.80 ± 0.24 ng/ml). Here, KITLG is linked to glioblastoma.